Role of Urinary 11-Dehydro Thromboxane B2 Quantification in Evaluating Anti-Platelet Drugs Resistance
Khaled Ahmed El-shourbagy;
Abstract
Aspirin is a well established medication in treatment and prevention of atherothrombotic disease. Despite aspirin treatment, a substantial number of patients experience recurrent ischemic episodes. These patients are clinically referred to as ‘aspirin res
Other data
| Title | Role of Urinary 11-Dehydro Thromboxane B2 Quantification in Evaluating Anti-Platelet Drugs Resistance | Other Titles | دور قياس11dhTxB2 الكمي في البول في تقيم المقاومة البيوكميائية للمرضى الذين يتعاطون أدويه مضادة للصفائح الدموية | Authors | Khaled Ahmed El-shourbagy | Keywords | Role of Urinary 11-Dehydro Thromboxane B2 Quantification in Evaluating Anti-Platelet Drugs Resistance | Issue Date | 1-Mar-2015 | Description | Aspirin is a well established medication in treatment and prevention of atherothrombotic disease. Despite aspirin treatment, a substantial number of patients experience recurrent ischemic episodes. These patients are clinically referred to as ‘aspirin res |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 110886p6172.pdf | 2.98 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.